SATIVEX
LIVE

Serial Number

79318507

Owner

GW Pharma Ltd

Filing Date

Jun 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SATIVEX Trademark

Serial Number: 79318507 • Registration: 7088758

SATIVEX is a trademark filed by GW Pharma Ltd on June 23, 2021. The trademark is classified under Class 41 (Education & Entertainment). The application is currently registered and active.

Owner Contact Info

GW Pharma Ltd (2 trademarks)

Sovereign House, Histon

Entity Type: 99

CNX THERAPEUTICS LIMITED (3 trademarks)

3 BUNHILL ROW
LONDON EC1Y 8YZ , GB

Entity Type: 24

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

Trademark Details

Filing Date

June 23, 2021

Registration Date

June 27, 2023

Published for Opposition

April 11, 2023

Goods & Services

Educational services, namely, providing online and in-person classes, seminars, training workshops, training classes, and presentations in the field of medicine, education, cannabis, pharmaceuticals, and healthcare; provision of training in the field of medical cannabidiol; pharmaceuticals instruction services, namely, providing courses of in the field of medical cannabidiol; educational services, namely, organising and conducting conferences, seminars, educational exhibitions and workshops in the field of medical cannabidiol; provision of on-line electronic publications in the nature of newsletters and factsheets in the field of medical cannabidiol; publication of texts, other than publicity texts; publication of scientific texts, other than publicity texts

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Apr 9, 2026 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2025 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 16, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 27, 2023 FICS
FINAL DISPOSITION PROCESSED
Sep 27, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 27, 2023 FICR
CHANGE OF OWNER RECEIVED FROM IB
Sep 25, 2023 CHLD
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 27, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 27, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Apr 19, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 22, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 22, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2023 CRFA
ASSIGNED TO LIE
Mar 6, 2023 ALIE
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 13, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 25, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 25, 2023 OPNR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2022 TROA
REFUSAL PROCESSED BY IB
Jul 12, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 23, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jun 23, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 18, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 17, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2022 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 27, 2022 ADCH
ASSIGNED TO EXAMINER
Mar 20, 2022 DOCK
ASSIGNED TO EXAMINER
Mar 15, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2021 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 15, 2021 COAR
APPLICATION FILING RECEIPT MAILED
Aug 31, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 26, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 19, 2021 SDRC